牛叉诊股

同花顺高级诊股公告

同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！同花顺高级诊股正式上线！提供全方位的深度分析，提供明确的投资建议，全程跟踪指导服务，欢迎点击查看！

同花顺特色产品: 〈高级诊股〉 全方位深度分析，提供明确投资建议

近岸蛋白（688137）

3.7

综合诊断：3.7分打败了4%的股票！

卖出
减持
中性
增持
买入

短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
中期趋势：
回落整理中且下跌趋势有所减缓。
长期趋势：
已有1家主力机构披露2025-12-31报告期持股数据，持仓量总计10.52万股，占流通A股0.32%
波段诊断：
-
历史波段诊断>>

高级诊股策略资深顾问建议

分享到：

加自选 向专家提问

技术面诊股资金面诊股消息面诊股行业面诊股基本面诊股

4.9分

3.0分

2.5分

1.6分

4.3分

风险提示：诊断结果通过运算模型加工客观数据而成，仅供参考，不构成绝对投资建议。

技术面诊股

诊断结果：4.9技术面打败了46%的股票技术面评分前10的股票

近期的平均成本为42.13元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

技术面得分最高的股票

平均成本

近期的平均成本为42.13元。

[{"text":"\u5e73\u5747\u6210\u672c","value":"42.13","date":1772441662,"color":"0x9f0ba1"}]

市场表现

过去10个交易日，该股走势明显跑输大盘，接近行业平均水平。

[{"date":"2026.03.03","stock":"-2.96","trade":"-2.99","ind":"-1.43"},{"date":"2026.03.02","stock":"-3.77","trade":"-2.61","ind":"0.47"},{"date":"2026.02.27","stock":"1.42","trade":"0.28","ind":"0.39"},{"date":"2026.02.26","stock":"-0.09","trade":"-0.72","ind":"-0.01"},{"date":"2026.02.25","stock":"-0.64","trade":"1.27","ind":"0.72"},{"date":"2026.02.24","stock":"0.53","trade":"0.43","ind":"0.87"},{"date":"2026.02.13","stock":"1.16","trade":"-0.55","ind":"-1.26"},{"date":"2026.02.12","stock":"-0.57","trade":"-0.47","ind":"0.05"},{"date":"2026.02.11","stock":"-1.29","trade":"-0.58","ind":"0.09"},{"date":"2026.02.10","stock":"-1.08","trade":"0.30","ind":"0.13"},{"date":"2026.02.09","stock":"1.32","trade":"0.78","ind":"1.41"},{"date":"2026.02.06","stock":"1.62","trade":"0.22","ind":"-0.25"},{"date":"2026.02.05","stock":"-0.73","trade":"-0.38","ind":"-0.64"},{"date":"2026.02.04","stock":"-1.36","trade":"0.70","ind":"0.85"},{"date":"2026.02.03","stock":"4.84","trade":"1.66","ind":"1.29"},{"date":"2026.02.02","stock":"-4.94","trade":"-2.66","ind":"-2.48"},{"date":"2026.01.30","stock":"-2.25","trade":"-1.26","ind":"-0.96"},{"date":"2026.01.29","stock":"-2.60","trade":"-1.58","ind":"0.16"},{"date":"2026.01.28","stock":"-5.90","trade":"-2.31","ind":"0.27"},{"date":"2026.01.27","stock":"-6.95","trade":"-0.80","ind":"0.18"},{"date":"2026.01.26","stock":"6.40","trade":"3.60","ind":"-0.09"}]

近岸蛋白,上证指数,生物制品指数

压力支撑

该股压力位为42.06元，支撑位为40.92元。

[{"text":"\u538b\u529b\u4f4d","value":"42.06","date":1772467200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"40.92","date":1772467200,"color":"0x0b52a1"}]

多空趋势

多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：3.0资金面打败了45%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力没有控盘。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

生物制品行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：03月03日 20:32

机构今日流向(万元)	-2249.86	机构5日流向(万元)	-7048.48
机构10日流向(万元)	-12144.33	机构20日流向(万元)	-28846.35

机构持仓

2025-12-31 与 2025-06-30 相比，主力机构持仓量减少1398.98万股，其中基金数没有增加，主力净减仓38家，请投资者中长期谨慎为宜。

截止2025-12-31，共1家主力机构（基金1家），持仓量总计10.52万股，占流通A股0.32%
其中，基金持仓与2025-06-30相比：
增仓：0家，增持 0万股
减仓：0家，减持 0万股
新出现在主力名单中：1家，持有10.52万股
从主力名单中消失：39家，原持有1409.5万股

消息面诊股

诊断结果：2.5消息面打败了6%的股票今日有利好新闻的公司

近期该股利空消息较多，投资时需谨慎。

消息面得分最高的股票

消息列表

重大利空	业绩预告	预计增亏	2026-01-31
一般消息	高管变动	取消监事会	2025-12-10
一般消息	股东大会	临时股东大会	2025-11-26
一般消息	分红转增	不分配不转增	2025-08-28
一般消息	分红转增	不分配不转增	2025-04-29

一年消息统计

	所有消息	重大消息	非重大消息
利好	0条	0条	0条
利空	1条	1条	0条

行业面诊股

诊断结果：1.6行业面打败了29%的股票生物制品行业最新资金流向

近10日来该行业走势总体向下，明显跑输大盘。

行业面得分最高的股票

行业走势

近10日来该行业走势总体向下，明显跑输大盘。

[{"date":"2026.03.03","price":"-1.43","value":"-2.99"},{"date":"2026.03.02","price":"0.47","value":"-2.61"},{"date":"2026.02.27","price":"0.39","value":"0.28"},{"date":"2026.02.26","price":"-0.01","value":"-0.72"},{"date":"2026.02.25","price":"0.72","value":"1.27"},{"date":"2026.02.24","price":"0.87","value":"0.43"},{"date":"2026.02.13","price":"-1.26","value":"-0.55"},{"date":"2026.02.12","price":"0.05","value":"-0.47"},{"date":"2026.02.11","price":"0.09","value":"-0.58"},{"date":"2026.02.10","price":"0.13","value":"0.30"},{"date":"2026.02.09","price":"1.41","value":"0.78"},{"date":"2026.02.06","price":"-0.25","value":"0.22"},{"date":"2026.02.05","price":"-0.64","value":"-0.38"},{"date":"2026.02.04","price":"0.85","value":"0.70"},{"date":"2026.02.03","price":"1.29","value":"1.66"},{"date":"2026.02.02","price":"-2.48","value":"-2.66"},{"date":"2026.01.30","price":"-0.96","value":"-1.26"},{"date":"2026.01.29","price":"0.16","value":"-1.58"},{"date":"2026.01.28","price":"0.27","value":"-2.31"},{"date":"2026.01.27","price":"0.18","value":"-0.80"},{"date":"2026.01.26","price":"-0.09","value":"3.60"}]

上证指数,生物制品行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	万泽股份	30.96%	-0.89%	6.2分
2	ST未名	13.67%	10.27%	5.1分
3	卫光生物	10.71%	-5.06%	5.6分
4	诺诚健华	7.80%	-9.04%	5.0分
5	欧林生物	3.16%	2.53%	5.4分
6	上海莱士	-0.47%	0.64%	5.3分
7	派林生物	-0.98%	4.64%	5.5分
8	三生国健	-1.71%	-3.76%	5.0分
9	通化东宝	-2.20%	-0.22%	4.5分
10	特宝生物	-2.31%	-1.15%	4.9分
11	辽宁成大	-2.94%	2.43%	5.6分
12	*ST四环	-4.21%	3.80%	5.7分
13	赛伦生物	-5.21%	-7.86%	4.5分
14	-	-5.36%	-7.67%	分
15	优宁维	-5.47%	-6.20%	4.9分
16	西藏药业	-6.06%	0.14%	5.0分
17	博晖创新	-7.08%	-6.50%	4.2分
18	博雅生物	-7.64%	-3.47%	4.5分
19	康辰药业	-7.69%	-6.48%	5.1分
20	成大生物	-7.89%	-2.66%	4.2分
21	天坛生物	-8.44%	-2.57%	4.7分
22	安科生物	-8.76%	-4.82%	4.5分
23	荣昌生物	-8.78%	-7.12%	4.7分
24	华兰生物	-9.10%	-1.49%	4.9分
25	*ST双成	-9.94%	-5.79%	5.3分
26	赛升药业	-10.01%	-7.86%	4.2分
27	艾迪药业	-10.63%	-3.55%	4.7分
28	义翘神州	-10.65%	-6.16%	4.9分
29	康希诺	-10.67%	7.36%	5.0分
30	凯因科技	-10.74%	-6.36%	4.2分
31	东宝生物	-10.94%	-8.95%	4.8分
32	长春高新	-11.63%	1.71%	4.3分
33	智翔金泰	-12.17%	-9.29%	4.0分
34	诺唯赞	-12.41%	-6.04%	4.2分
35	甘李药业	-12.61%	-5.36%	4.8分
36	百克生物	-12.97%	-5.09%	3.8分
37	昊帆生物	-13.03%	-8.91%	4.3分
38	康泰生物	-13.34%	-7.36%	3.7分
39	康弘药业	-13.55%	-5.66%	4.5分
40	禾元生物	-13.90%	-1.99%	4.4分
41	百奥泰	-14.49%	-9.47%	4.2分
42	康华生物	-16.24%	-10.46%	4.2分
43	我武生物	-18.18%	-9.95%	4.1分
44	华兰疫苗	-18.38%	-9.29%	5.0分
45	迈威生物	-18.39%	-10.16%	4.3分
46	神州细胞	-19.35%	-6.33%	3.9分
47	智飞生物	-19.50%	-6.60%	4.4分
48	科兴制药	-19.76%	-6.95%	4.5分
49	-	-19.86%	-7.84%	分
50	君实生物	-21.02%	-12.52%	4.2分
51	沃森生物	-21.06%	-5.77%	4.0分
52	-	-21.19%	-8.00%	分
53	近岸蛋白	-22.26%	-5.98%	3.7分
54	金迪克	-27.29%	-7.41%	3.8分
55	百普赛斯	-28.72%	-10.97%	4.6分

<上一页 1 2 3 4 5...10 下一页>

行业评级

研究机构	评级日期	最新评级	上次评级
暂无相关评级

基本面诊股

诊断结果：4.3基本面打败了3%的股票连续3年业绩增长30%的公司

该公司运营状况不佳，暂时未获得多数机构的显著认同，长期投资价值一般。

个股深一度

潜在高分红能力：弱（72.5分）

基本面得分最高的股票

[ 截止日期：2025-09-30 ]公司经营

盈利能力：较强，高于行业平均，两项指标的行业排名分别为 39/71 ， 35/71。

[{"date":"2025-09-30","value":"-1.38","vol":"-9.78"},{"date":"2025-06-30","value":"-1.16","vol":"-0.61"},{"date":"2025-03-31","value":"-0.56","vol":"0.46"},{"date":"2024-12-31","value":"-2.54","vol":"-0.68"},{"date":"2024-09-30","value":"-0.84","vol":"1.34"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净资产收益率(%)	-1.38	-1.16	-0.56	-2.54	-0.84
行业(%)	-9.78	-0.61	0.46	-0.68	1.34

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"64.84","vol":"67.61"},{"date":"2025-06-30","value":"64.47","vol":"68.28"},{"date":"2025-03-31","value":"62.26","vol":"68.43"},{"date":"2024-12-31","value":"62.38","vol":"69.85"},{"date":"2024-09-30","value":"64.54","vol":"70.47"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
销售毛利率(%)	64.84	64.47	62.26	62.38	64.54
行业(%)	67.61	68.28	68.43	69.85	70.47

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：一般，低于行业平均，两项指标的行业排名分别为 17/71 ， 42/71。

[{"date":"2025-09-30","value":"21.48","vol":"45.25"},{"date":"2025-06-30","value":"20.85","vol":"6902.04"},{"date":"2025-03-31","value":"28.20","vol":"6125.27"},{"date":"2024-12-31","value":"-16.73","vol":"47.35"},{"date":"2024-09-30","value":"-16.83","vol":"175.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
营业收入同比增长率(%)	21.48	20.85	28.20	-16.73	-16.83
行业(%)	45.25	6902.04	6125.27	47.35	175.00

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"-58.06","vol":"44.80"},{"date":"2025-06-30","value":"-172.00","vol":"5.44"},{"date":"2025-03-31","value":"-348.91","vol":"-8.46"},{"date":"2024-12-31","value":"-523.68","vol":"-9.81"},{"date":"2024-09-30","value":"-215.00","vol":"-52.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
净利润同比增长率(%)	-58.06	-172.00	-348.91	-523.68	-215.00
行业(%)	44.80	5.44	-8.46	-9.81	-52.40

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：一般，低于行业平均，两项指标的行业排名分别为 50/71 ， 38/71。

[{"date":"2025-09-30","value":"0.05","vol":"0.22"},{"date":"2025-06-30","value":"0.03","vol":"0.14"},{"date":"2025-03-31","value":"0.02","vol":"0.06"},{"date":"2024-12-31","value":"0.06","vol":"0.29"},{"date":"2024-09-30","value":"0.04","vol":"0.22"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
总资产周转率(次)	0.05	0.03	0.02	0.06	0.04
行业(次)	0.22	0.14	0.06	0.29	0.22

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.54","vol":"0.92"},{"date":"2025-06-30","value":"0.36","vol":"0.56"},{"date":"2025-03-31","value":"0.17","vol":"0.26"},{"date":"2024-12-31","value":"0.60","vol":"1.17"},{"date":"2024-09-30","value":"0.40","vol":"0.86"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
存货增长率(次)	0.54	0.36	0.17	0.60	0.40
行业(次)	0.92	0.56	0.26	1.17	0.86

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2025-09-30","value":"-8.59","vol":"1.84"},{"date":"2025-06-30","value":"-2.09","vol":"-1377.61"},{"date":"2025-03-31","value":"-39.69","vol":"-46.99"},{"date":"2024-12-31","value":"-18.41","vol":"-11.33"},{"date":"2024-09-30","value":"-10.65","vol":"-30.88"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
现金流量净额/营业收入	-8.59	-2.09	-39.69	-18.41	-10.65
行业	1.84	-1377.61	-46.99	-11.33	-30.88

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.53","vol":"1.59"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.26","vol":"2.01"},{"date":"2024-09-30","value":"","vol":"0.00"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资本支出／折旧和摊销	-	1.53	-	1.26	-
行业	0.00	1.59	0.00	2.01	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 50/71 ， 47/71。

[{"date":"2025-09-30","value":"25.67","vol":"6.00"},{"date":"2025-06-30","value":"25.93","vol":"6.64"},{"date":"2025-03-31","value":"25.98","vol":"7.75"},{"date":"2024-12-31","value":"29.13","vol":"6.72"},{"date":"2024-09-30","value":"36.07","vol":"7.02"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
流动比率	25.67	25.93	25.98	29.13	36.07
行业	6.00	6.64	7.75	6.72	7.02

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"11.73","vol":"4.84"},{"date":"2025-06-30","value":"11.47","vol":"5.30"},{"date":"2025-03-31","value":"10.22","vol":"6.35"},{"date":"2024-12-31","value":"10.63","vol":"5.40"},{"date":"2024-09-30","value":"13.49","vol":"5.66"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
速动比率	11.73	11.47	10.22	10.63	13.49
行业	4.84	5.30	6.35	5.40	5.66

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：较强，高于行业平均，两项指标的行业排名分别为 47/71 ， 46/71。

[{"date":"2025-09-30","value":"5.23","vol":"28.18"},{"date":"2025-06-30","value":"5.30","vol":"26.73"},{"date":"2025-03-31","value":"5.49","vol":"26.03"},{"date":"2024-12-31","value":"5.25","vol":"25.81"},{"date":"2024-09-30","value":"4.85","vol":"24.44"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
资产负债率(%)	5.23	5.30	5.49	5.25	4.85
行业(%)	28.18	26.73	26.03	25.81	24.44

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2025-09-30","value":"0.06","vol":"0.58"},{"date":"2025-06-30","value":"0.06","vol":"1.11"},{"date":"2025-03-31","value":"0.06","vol":"0.78"},{"date":"2024-12-31","value":"0.06","vol":"0.87"},{"date":"2024-09-30","value":"0.05","vol":"0.40"}]

	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
产权比率 (%)	0.06	0.06	0.06	0.06	0.05
行业(%)	0.58	1.11	0.78	0.87	0.40

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构对该股票关注较少，无任何评级。

研究机构	评级日期	最新评级	上次评级
暂无数据

机构预测

暂时还没有机构预测该股2025年的收益，请投资者后续关注。

[{"date":"2021","yellowRectValue":"1.49","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"0.91","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.13","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-0.54","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]

[近岸蛋白]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]